{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T08:19:41Z","timestamp":1769329181770,"version":"3.49.0"},"reference-count":50,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,1,5]]},"DOI":"10.18632\/oncotarget.23326","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T10:15:41Z","timestamp":1513419341000},"page":"2017-2027","source":"Crossref","is-referenced-by-count":13,"title":["microRNA-19a protects osteoblasts from dexamethasone via targeting TSC1"],"prefix":"10.18632","volume":"9","author":[{"given":"Gang","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Huai\u2019an First People's Hospital, Nanjing Medical University, Huai\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Li","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Huai\u2019an First People's Hospital, Nanjing Medical University, Huai\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Huai\u2019an First People's Hospital, Nanjing Medical University, Huai\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Dong","family":"Fei","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Huai\u2019an First People's Hospital, Nanjing Medical University, Huai\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Huai\u2019an First People's Hospital, Nanjing Medical University, Huai\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-Guo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Huai\u2019an First People's Hospital, Nanjing Medical University, Huai\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11926-011-0173-y","article-title":"Advances in glucocorticoid-induced osteoporosis","volume":"13","author":"Lems","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Clinical practice. Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jsbmb.2009.02.007","article-title":"Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action","volume":"114","author":"Harvey","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbrc.2015.02.161","article-title":"Dexamethasone-induced apoptosis of osteocytic and osteoblastic cells is mediated by TAK1 activation","volume":"460","author":"Li","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00774-008-0019-5","article-title":"Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta","volume":"27","author":"Chung","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbrc.2016.10.104","article-title":"MHY1485 activates mTOR and protects osteoblasts from dexamethasone","volume":"481","author":"Xie","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bbrc.2015.02.007","article-title":"K6PC-5, a novel sphingosine kinase 1 (SphK1) activator, alleviates dexamethasone-induced damages to osteoblasts through activating SphK1-Akt signaling","volume":"458","author":"Fei","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bbrc.2015.11.104","article-title":"alpha-Melanocyte stimulating hormone attenuates dexamethasone-induced osteoblast damages through activating melanocortin receptor 4-SphK1 signaling","volume":"469","author":"Fei","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.bbrc.2016.02.036","article-title":"Activating AMP-activated protein kinase by an alpha1 selective activator compound 13 attenuates dexamethasone-induced osteoblast cell death","volume":"471","author":"Wang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.bbrc.2017.04.111","article-title":"PP2A catalytic subunit silence by microRNA-429 activates AMPK and protects osteoblastic cells from dexamethasone","volume":"487","author":"Xie","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"11","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.18632\/oncotarget.13732","article-title":"Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"12","doi-asserted-by":"publisher","first-page":"10543","DOI":"10.18632\/oncotarget.14454","article-title":"Targeted activation of AMPK by GSK621 ameliorates H2O2-induced damages in osteoblasts","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"13","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/jcp.24589","article-title":"P53 dependent mitochondrial permeability transition pore opening is required for dexamethasone-induced death of osteoblasts","volume":"229","author":"Wang","year":"2014","journal-title":"J Cell Physiol"},{"key":"14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bbrc.2014.04.002","article-title":"EGFR trans-activation mediates pleiotrophin-induced activation of Akt and Erk in cultured osteoblasts","volume":"447","author":"Cui","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"15","doi-asserted-by":"publisher","first-page":"e37030","DOI":"10.1371\/journal.pone.0037030","article-title":"Glucocorticoid receptor and sequential P53 activation by dexamethasone mediates apoptosis and cell cycle arrest of osteoblastic MC3T3-E1 cells","volume":"7","author":"Bian","year":"2012","journal-title":"PLoS One"},{"key":"16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Guan","year":"2002","journal-title":"Nat Cell Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1081\/CNV-200027144","article-title":"The tuberous sclerosis complex genes in tumor development","volume":"22","author":"Yeung","year":"2004","journal-title":"Cancer Invest"},{"key":"18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Sabatini","year":"2012","journal-title":"Cell"},{"key":"20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"Sabatini","year":"2017","journal-title":"Cell"},{"key":"21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11010-014-2210-4","article-title":"EGFR-AKT-mTOR activation mediates epiregulin-induced pleiotropic functions in cultured osteoblasts","volume":"398","author":"Cui","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","article-title":"Endogenous microRNA sponges: evidence and controversy","volume":"17","author":"Dinger","year":"2016","journal-title":"Nat Rev Genet"},{"key":"23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing","volume":"16","author":"Izaurralde","year":"2015","journal-title":"Nat Rev Genet"},{"key":"24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrg3162","article-title":"MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship","volume":"13","author":"Pasquinelli","year":"2012","journal-title":"Nat Rev Genet"},{"key":"25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Guan","year":"2003","journal-title":"Cell"},{"key":"26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis","volume":"121","author":"Pandolfi","year":"2005","journal-title":"Cell"},{"key":"27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1","volume":"11","author":"Sabatini","year":"2006","journal-title":"Dev Cell"},{"key":"28","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","article-title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination","volume":"19","author":"DeClue","year":"2000","journal-title":"Oncogene"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Liu, Thoreen, Wang, Sabatini, Gray. mTOR Mediated Anti-Cancer Drug Discovery. Drug Discov Today Ther Strateg. 2009; 6:47\u201355. https:\/\/doi.org\/10.1016\/j.ddstr.2009.12.001.","DOI":"10.1016\/j.ddstr.2009.12.001"},{"key":"30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Sabatini","year":"2007","journal-title":"Cancer Cell"},{"key":"31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejca.2007.10.003","article-title":"The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics","volume":"44","author":"Piccart","year":"2008","journal-title":"Eur J Cancer"},{"key":"32","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1002\/cncr.24280","article-title":"A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer","volume":"115","author":"Willis","year":"2009","journal-title":"Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sabatini","year":"2006","journal-title":"Mol Cell"},{"key":"34","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sabatini","year":"2004","journal-title":"Curr Biol"},{"key":"35","doi-asserted-by":"crossref","first-page":"19445","DOI":"10.1074\/jbc.C500125200","article-title":"Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site","volume":"280","author":"Sabatini","year":"2005","journal-title":"J Biol Chem"},{"key":"36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molcel.2008.04.012","article-title":"AMPK and Raptor: matching cell growth to energy supply","volume":"30","author":"Hardie","year":"2008","journal-title":"Mol Cell"},{"key":"37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrc.2016.09.027","article-title":"SC79 rescues osteoblasts from dexamethasone though activating Akt-Nrf2 signaling","volume":"479","author":"Zhou","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.freeradbiomed.2014.01.025","article-title":"Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2\/HO-1 signaling","volume":"69","author":"Yao","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"39","doi-asserted-by":"publisher","first-page":"25525","DOI":"10.1038\/srep25525","article-title":"3H-1,2-dithiole-3-thione protects retinal pigment epithelium cells against Ultra-violet radiation via activation of Akt-mTORC1-dependent Nrf2-HO-1 signaling","volume":"6","author":"Cao","year":"2016","journal-title":"Sci Rep"},{"key":"40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","article-title":"Molecular basis of the Keap1-Nrf2 system","volume":"88","author":"Yamamoto","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.taap.2009.08.018","article-title":"A systems biology perspective on Nrf2-mediated antioxidant response","volume":"244","author":"Andersen","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"42","doi-asserted-by":"publisher","first-page":"44326","DOI":"10.1074\/jbc.M111.283481","article-title":"Glucocorticoids and tumor necrosis factor alpha increase oxidative stress and suppress Wnt protein signaling in osteoblasts","volume":"286","author":"Manolagas","year":"2011","journal-title":"J Biol Chem"},{"key":"43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bone.2014.12.012","article-title":"Prevention of glucocorticoid induced-apoptosis of osteoblasts and osteocytes by protecting against endoplasmic reticulum (ER) stressandin female mice","volume":"73C","author":"Bellido","year":"2015","journal-title":"Bone"},{"key":"44","doi-asserted-by":"publisher","first-page":"24120","DOI":"10.1074\/jbc.M611435200","article-title":"Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival. Evidence for inside-out signaling leading to anoikis","volume":"282","author":"Bellido","year":"2007","journal-title":"J Biol Chem"},{"key":"45","doi-asserted-by":"publisher","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Pickett","year":"2009","journal-title":"J Biol Chem"},{"key":"46","doi-asserted-by":"publisher","first-page":"15960","DOI":"10.1074\/jbc.M110.121871","article-title":"FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1","volume":"285","author":"Plas","year":"2010","journal-title":"J Biol Chem"},{"key":"47","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.neuroscience.2014.10.066","article-title":"Targeting thioredoxin-1 with siRNA exacerbates oxidative stress injury after cerebral ischemia\/reperfusion in rats","volume":"284","author":"Zhao","year":"2015","journal-title":"Neuroscience"},{"key":"48","doi-asserted-by":"publisher","first-page":"60123","DOI":"10.18632\/oncotarget.11164","article-title":"SC79 protects retinal pigment epithelium cells from UV radiation via activating Akt-Nrf2 signaling","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"49","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.4049\/jimmunol.1402163","article-title":"5-lipoxygenase is a direct target of miR-19a-3p and miR-125b-5p","volume":"194","author":"Steinhilber","year":"2015","journal-title":"J Immunol"},{"key":"50","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1073\/pnas.1320577111","article-title":"MicroRNAs are critical regulators of tuberous sclerosis complex and mTORC1 activity in the size control of the Xenopus kidney","volume":"111","author":"Wessely","year":"2014","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:48:57Z","timestamp":1589021337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1,5]]}},"alternative-id":["23326","29416749"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.23326","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,15]]}}}